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Hematopoietic stem cells (HSCs) continuously
regenerate the hematologic system, yet few
genes regulating this process have been de-
fined. To identify candidate factors involved in
differentiation and self-renewal, we have gener-
ated an expression database of hematopoietic
stem cells and their differentiated progeny, in-
cluding erythrocytes, granulocytes, monocytes,
NK cells, activated and naive T cells, andBcells.
Bioinformatic analysis revealedHSCsweremore
transcriptionally active than their progeny and
shared a common activation mechanism with
T cells. Each cell type also displayed unique
biases in the regulation of particular genetic
pathways, with Wnt signaling particularly en-
hanced in HSCs. We identified100–400 genes
uniquely expressed in each cell type, termed
lineage ‘‘fingerprints.’’ In overexpression stud-
ies, two of these genes, Zfp105 from the NK cell
lineage, and Ets2 from the monocyte lineage,
were able to significantly influence differentia-
tion toward their respective lineages, demon-
strating the utility of the fingerprints for identify-
ing genes that regulate differentiation.
INTRODUCTION
Hematopoiesis entails differentiation of the hematopoietic
stem cell (HSC) through progenitor intermediates to termi-
nally differentiated blood cells exhibiting vastly different
morphologies and functions. The transcriptional control
of HSC differentiation is still poorly understood, despite
advances in mouse genetics that have elucidated the
role of certain pivotal molecules within the developmental578 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elsevierhierarchy. A few transcription factors have been shown
to be essential for specific lineages: for example, early B
cell factor-1 (ebf1) in B lymphocytes (Lin and Grosschedl,
1995), and gata2 in megakaryocytic differentiation (Ling
et al., 2004; Orkin et al., 1998). However, the number of
genes demonstrated to be critical for differentiation within
most hematopoietic lineages is extremely small. The few
global approaches that have been used to study regulation
of hematopoietic cells have focusedeitheroncomparisons
between HSCs and other stem cell types (Ivanova et al.,
2002; Ramalho-Santos et al., 2002), or between HSCs
and pools of their differentiated progeny (Toren et al.,
2005), which limits the ability to identify candidate regula-
tors due to the choice of the comparator populations.
We have taken a systematic approach to identify genes
uniquely expressed in murine HSCs, as well as in their
differentiated counterparts. Bioinformatics enabled inves-
tigation of lineage relationships, dominant genetic path-
ways, and chromatin status in HSCs versus differentiated
cells. We also identified ‘‘fingerprints’’ for each cell type
comprised of genes uniquely expressed therein, and we
show that at least two of these fingerprint genes partici-
pate in regulation of cell-type identity. These studies
have uncovered a number of genes as novel candidate
regulators of HSCs and their differentiated progeny, many
of which will be of interest for therapeutic modulation of
these populations.
RESULTS
To identify genes uniquely expressed in HSCs and their
differentiated progeny, we took a global gene expression
profiling approach, determining in parallel the transcribed
genome of known coding transcripts in HSCs as well as
their major differentiated lineage, including natural killer
(NK) cells, T cells, B cells, monocytes, neutrophils, and
nucleated erythrocytes. Because we were particularly
interested in potential similarities between HSCs andInc.
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Hematopoietic Fingerprints: An Expression DatabaseFigure 1. Global Transcription Profile
Analysis Reveals Hematopoietic Cell
Ontogeny
Expression differences between microarrays
were assessed on the basis of cluster analysis
and principal components analysis (PCA).
(A) A dendrogram displays distance in a
branching fashion where the right-most branch
point indicates the cell types with the highest
degree of similarity, with replicates most simi-
lar. The HSCs are most transcriptionally similar
to lymphocytes, with activated T cells quite
distinct.
(B) When relative distance is collapsed to two
dimensions using PCA, the HSC arrays reside
at a midpoint between lymphocytes, myeloid
cells, and erythrocytes.T cells, we examined both activated and naive CD4+
(helper) and CD8+ (cytotoxic) T cell subsets. Each popula-
tion was purified to at least 95% purity, and multiple pa-
rameters were standardized to reduce technical variation
(see Table S1 and Supplemental Experimental Proce-
dures in the Supplemental Data available with this article
online). RNA from the samples was processed and hybrid-
ized to Affymetrix MOE430 2.0 microarrays, which have
probe sets representing about 20,000 genes. The entire
data set is available (Table S2) in GEO (accession
number GSE6506), and a gene-by-gene query can be per-
formed (http://franklin.imgen.bcm.tmc.edu/loligag/).
Gene Expression Patterns Reflect Ontogeny
We first used the data set to investigate assumptions con-
cerning relatedness of the hematopoietic cell types, as the
similarity of gene expression profiles between different
populations is thought to reflect their ontogeny relation-
ships (Puthier et al., 2004) and may shed light on the
debate regarding their developmental origins. We used
cluster analysis to assess relative distance of the tran-
scriptome of each cell type, resulting in a branched ‘‘family
tree’’ based on the similarity between overall transcription
patterns (Figure 1A). The HSCs clustered with the lym-
phocytes, supporting a recent report that HSCs and
lymphocytes share many similarities, and may indicate
a conservedmechanism between HSCs and lymphocytes
of long-term quiescence interrupted by bursts of prolifer-
ative stimuli (Luckey et al., 2006). Also noteworthy is the
very distinct nature of the activated T cells (both CD4+
and CD8+).
We used principal components analysis (PCA) to further
explore the cell-type relationships. When the relative ex-
pression distance between each averaged chip pair was
examined with PCA in the two dimensions that contain
the greatest variance within the data (first and second
principal components; PC1, PC2), we found the cell types
cluster on the basis of ontogeny, with the stem cell having
a centralized position (Figure 1B). This analysis reveals the
striking segregation of lymphoid, myeloid, and erythroid
cells into three discrete clusters. Both cluster analysis
and PCA indicate that erythrocytes are distant from mye-
loid cells (monocytes, granulocytes), supporting a recentCell Sobservation that they arise independently of a common
myeloid progenitor (Adolfsson et al., 2005).
Genetic Fingerprints Unique to Each Cell Type
We next examined the data to determine whether there
were genes exclusively expressed by particular cell types.
Such a genetic ‘‘fingerprint’’ would be expected to contain
some genes encoding proteins involved in unique cell
functions, as well as regulatory proteins that may direct
expression of other genes in the fingerprint.
We defined fingerprint genes as those that were ‘‘on’’ in
one cell type, and ‘‘off’’ in all other profiles by establishing
expression thresholds above and below a conservative
window selected by real-time PCR (Figure S1). An expres-
sion value of 5 or greater was considered ‘‘on,’’ and 4 or
less was considered ‘‘off’’ (log[2] scale). Examples of
uniquely expressed genes found in fingerprints are eco-
tropic viral integration site-1 (Evi1), a known proto-onco-
gene (Mucenski et al., 1988) and the most differentially
expressed gene in HSCs, killer cell lectin-like receptor
family E member-1 (Klre1), an NK cell receptor (Wilhelm
and Mager, 2003), and T cell receptor alpha on T cells
(Figure 2A).
The filter was also applied to groups of cell types to de-
termine a ‘‘shared’’ fingerprint for all differentiated cells, as
well as the lymphoid (NK, T, and B cells) and myeloid
(monocytes and granulocytes) branches, which defined
mutually expressed genes excluded from other cells
(Figure 2B). Strikingly, expression of the gene for the cell
surface marker CD48 identifies all the differentiated cell
types, but not HSCs, consistent with recent reports (Kiel
et al., 2005). Similarly, CD2 expression marks the lym-
phoid lineage, and Trem1 the myeloid lineage. For the
purpose of identifying a T cell fingerprint, we chose to
combine both types of naive T cells and exclude the acti-
vated T cells in order to uncover genes responsible for
T cell differentiation and not T cell activation.
Each cell-type fingerprint contained 40–100 genes, ex-
cept the HSC and erythroid cell fingerprints, which both
had 350 genes (Figure 2C and Table S3). The shared
lymphoid fingerprint, representing genes shared by all
lymphoid cells and excluded from stem cells, contained
only 18 genes, reflecting their similarity to stem cells.tem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 579
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The normalized (log2) expression intensity is shown. The gray line indicates the threshold window, above which a gene was considered to be
expressed, and below which, nonexpressed, for selection of uniquely expressed genes in the ‘‘fingerprints.’’ (A) Shown are three examples of genes
expressed in a specific cell type, or (B) a group of cell types including all differentiated cells, lymphocytes, or myeloid cells. The fingerprints are sum-
marized in a heat map (color indicates normalized expression level [log2]; darker corresponds to higher expression). (C) Cell-type specific fingerprints,
and (D) shared fingerprints.The myeloid fingerprint contained 154 genes, and 36
genes were shared among all differentiated cells. Finally,
there were 9000 genes expressed by all hematopoietic
cells (Table S3); many are likely ubiquitously expressed
housekeeping genes, but some may be unique to the
entire hematopoietic system, such as CD45.
The fingerprints contain some genes known to be
important for the function of certain cell types, such as
Gata1 in the erythroid lineage (Evans et al., 1988; Wall
et al., 1988) and the CSF1 receptor (Csf1r) in themonocyte
lineage (Roussel and Sherr, 1989), validating the approach
for identification of cell-type-specific genes (Figure 3A), as
well asmany under-studied genes that may have a regula-
tory role or serve as novel markers. Likewise, the shared580 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elsevierfingerprint genes are either required for the function of all
family cell types, such as Atm in the lymphoid fingerprint
(Ito et al., 2004), or for differentiation of the cell-type family
(Figure 3A). We predict that common progenitors will ex-
press some of the shared fingerprint genes (Figures 3A
and 3B), which could be developed as tools for markers
of those progenitors, or as regulators of their fate.
To assess whether deficiencies of fingerprint genes re-
sult in hematopoietic defects, we examined phenotypes in
theJaxMouseGenome Informaticsdatabase (MGI; v.3.44)
for all genes that had a reported knock-out allele. Remark-
ably, several fingerprint genes with available knockouts
show defects in either differentiation or functionality of a
lineage (Figure 3C and Table 1). A striking example fromInc.
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(A) Selected genes from each of the cell-type and shared fingerprints are shown in context with their developmental relationships.
(B) A Venn diagram summarizes the number of shared genes in the different fingerprints.
(C) Venn diagram summarizes the number of knockout mice with hematopoietic phenotypes in each of the indicated gene groups. Not all cell types
and intersections are shown.the B cell fingerprint is the Ebf1 knockout, which exhibits a
complete loss of B cells (Lin and Grosschedl, 1995). Like-
wise, ablation ofHoxA9, anHSCfingerprint gene, results in
severely impaired HSCs (Lawrence et al., 2005). All finger-
prints, with one exception, demonstrated a statistically
significantenrichment forgenesexhibitingahematopoietic
phenotype when knocked out (defined by MGI as either
‘‘hematopoietic system’’ or ‘‘immune system’’ pheno-
types) (z-test, Table S4). Only the 9000 gene common fin-
gerprint was not found to be enriched for a hematopoietic
phenotype, most likely due to the preponderance of
housekeeping genes in this list.
HSCs and T Cells Share a Similar Transcriptional
Program of Activation
Anecdotal observations have suggested that HSCs and
T cells share a number of markers as well as regulatoryCellgenes. These similarities could result from a similar life-
style of long-term quiescence followed by expansion
(Luckey et al., 2006), or could be related to the evolution-
ary history of the hematopoietic system; specifically, HSC
transcription factors may have been adapted for lympho-
cyte development and maintained for T cell differentiation
(Rothenberg and Pant, 2004). Becausewewere interested
in a potential relationship between HSCs and T cells, and
also the similarity between HSC activation and T cell
activation, we examined this in greater detail.
Cluster analysis was repeated with T cell data alone.
This analysis again showed the importance of activa-
tion for distinguishing T cell subtypes compared to their
CD4/CD8 status (Figure 4A). We next compared the acti-
vated versus naive T cell data to our previous study, in
which we identified genes that change during HSC activa-
tion, as stimulated by 5-fluorouracil treatment (VeneziaStem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 581
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T cell data were analyzed independently of other cell types.
(A) Cluster analysis indicates that activation state drives T cell subset differences.
(B) Genes involved in T cell activation are upregulated during HSC activation. A pairwise comparison between naive and activated T cells (including
bothCD4+ andCD8+ cells) was used to generate a list of genes upregulated in activated or naive T cells. Themean expression values of genes in these
lists (up-in-naive and up-in-activated) were plotted from the HSC activation time course data. Genes upregulated during T cell activation were
upregulated during HSC activation (top panel), peaking at day 6 when HSCs are most highly replicating, mirroring genes in the HSC proliferation
signature (P-sig). Genes upregulated in naive T cells were downregulated during HSC activation (bottom panel), as genes in the quiescence signature
(Q-sig). The p value is from a one-way ANOVA for significant changes across the 5-fluorouracil time course.
(C) A T cell fingerprint independent of the other cell types.
(D) Shared fingerprints for CD4+, CD8+, and naive and activated T cells were also identified. Gene list sizes are indicated to the right side of each heat
map (color indicates normalized expression level [log2]; darker corresponds to higher expression).et al., 2004). A list of genes that differ between activated
and naive T cells was generated from a pairwise compar-
ison. The average expression values of these genes in
HSCs over the activation time course were then plotted.
On average, genes that were upregulated in activated
T cells were also upregulated in activated HSCs (Fig-
ure 4B; genes increasing in expression on days 2–6 of HSC
activation; one-way ANOVA p % 5.23 3 104, alpha =
0.05), whereas naive T cell genes have the reciprocal sig-
nature, being more highly expressed in quiescent HSCs
(p % 3.44 3 103, alpha = 0.05). This analysis suggests
that the mechanisms that regulate the activation state in
HSCs and T cells may be similar.
We next sought to identify genes distinguishing the T
cell subsets, irrespective of their expression pattern in
the other hematopoietic cells, using the same threshold
criteria applied to the hematopoietic fingerprints. For
each T cell type, the number of genes uniquely expressed
in each ranged from 13 (CD4 activated) to 73 (CD4 naive)
(Figure 4C and Table S5). This strategy also revealed that
the number of genes shared between activated and naive
CD4+ T cells, but excluded from their CD8+ counterparts,
was only four; included is Zbtb7b, a gene that permits
selection of CD4+ T cells in the thymus (Sun et al., 2005).
Activated and naive CD8+ cells shared eleven genes, in-582 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elseviercluding the a and b chains of CD8 (Figure 4D). However,
the CD4+ and CD8+ naive T cells shared 215 genes with
each other, while the activated cells shared 174, empha-
sizing the dramatic changes helper and effector T cells
undergo during activation (Figure 4A and Table S4). As
expected, activated T cells upregulated markers such as
Il2ra (CD25) (Crabtree, 1989) and Icos (Flesch, 2002).
This list includes a substantial number of undercharac-
terized genes, such as two Riken clones confirmed by
RT-PCR (3110082i17Rik and 4933403f05Rik, Figure S4)
named Heist (for higher expression in stimulated T cells)
1 and 2.
Lineages Enriched for Key Pathways
To investigate whether certain signaling or metabolic
pathways are likely to be operating in specific cell types,
we utilized the Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) to group genes into specific pathways
(Ogata et al., 1999). The mean expression value for all
arrayed genes in each pathway was determined for every
cell type, and categories with significant variation (i.e., dif-
ference between the cell types; 65 categories; ANOVA
p value% 0.05, alpha = 0.05) were displayed (Figure 5 and
Figure S2). Notably, genes involved in Wnt signaling
were overrepresented in HSCs, consistent with a putativeInc.
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Hematopoietic Cells Using KEGG
KEGG was used to identify which cell types
exhibit an over- or underabundance of compo-
nents of molecular pathways, with significant
differences between cell types determined by
an ANOVA (one way, a = 0.05). For pathways
containing genes found on the array, the
mean expression value for all genes within
a pathway for each cell type is displayed as
a function of color (yellow corresponds to low
average expression, dark blue to high). Path-
ways are ordered by high expression within
a cell type from left to right. Below the heat
map, the number of neutral to overabundant
categories is denoted, and the percent of those
pathways that are signaling and metabolic is
indicated. This method identified differences
in KEGG pathway activity between the cell
types; pathways equally active in all cell types
will not appear significant.role for this pathway in cell fate decisions (Kirstetter et al.,
2006; Reya et al., 2003; Scheller et al., 2006). In addition,
we find prostaglandin and leukotriene metabolism en-
riched in myeloid cells, and Notch signaling enriched in
HSCs, activated CD8+ T cells, and monocytes.
The KEGG database contains six categories with some
redundancy; therefore we chose to classify the 65 signi-
ficant pathways as either metabolism or signaling and
assess each cell type for abundance within these two
pathways. Myeloid cells displayed the greatest abun-
dance of both metabolic and signaling pathways. T cells
showed a pattern of increasing metabolic pathways and
decreasing signaling pathways upon activation. B cells
and NK cells showed a greater abundance of signaling
pathways, perhaps indicative of their role as primary
sensors of the immune system. Nucleated erythrocytes
displayed lower abundance of signaling pathways and a
greater proportion of metabolic pathways, as would beCell Sexpected during the final stages of erythrocyte differenti-
ation. HSCs showed the third highest abundance of active
pathways with signaling pathways represented most,
consistent with a state of differentiation readiness.
Bioinformatic Analysis Indicates HSCs Have an
Open Chromatin State
Stem cells have been speculated to maintain an open
chromatin state in order to facilitate rapid differentiation
(Akashi et al., 2003; Hu et al., 1997). This is consistent with
the idea of stem cell ‘‘priming,’’ where progenitors may
express low levels of genes necessary for multiple differ-
entiation programs, most of which become repressed as
lineage choices become restricted during differentiation
(Hu et al., 1997; Jimenez et al., 1992). This suggests a ma-
jor role for chromatin remodeling during differentiation.
We probed chromatin status using high-level analysis
of our gene expression data, reasoning that ‘‘open’’tem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 583
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Fingerprint Gene Name
Gene
Symbol Knockout Phenotypes from MGI
HSCs GATA binding protein 2 Gata2 Abnormal hematopoiesis
Myeloproliferative leukemia virus oncogene Mpl Abnormal hematopoiesis
Endoglin Eng Abnormal hematopoiesis
Endothelial-specific receptor tyrosine kinase Tek Abnormal vasculogenesis
Neuroblastoma myc-related oncogene 1 Nmyc1 Embryonic lethality
Ecotropic viral integration site 1 Evi1 Embryonic lethality
B cells Early B cell factor 1 Ebf1 B cells fail to mature
Immunoglobulin heavy chain (gamma polypeptide) Ighg NA
CD79A antigen (immunoglobulin-associated alpha) Cd79a Arrested B cell development and
decreased B cell number
CD37 antigen Cd37 Decreased IgG, abnormal B cell
response
B cell CLL/lymphoma 11A (zinc finger protein) Bcl11a B cell deficiency
T cells, naive Transducin (beta)-like 1 X-linked Tbl1x NA
IL2-inducible T cell kinase Itk Decreased T cell proliferation
Cytotoxic T-lymphocyte-associated protein 4 Ctla4 Spontaneous T cell proliferation
Interleukin 2 receptor, alpha chain Il2ra Anemia, lymphocyte defects
T cell receptor alpha chain Tcra Abnormal T cell development
NK cells Zinc finger protein 105 Zfp105 NA
Killer cell lectin-like receptor family E member 1 Klre1 Defective NK cell cytolysis
Fas ligand (TNF superfamily, member 6) Fasl Increased T cell and neutrophil number
Killer cell lectin-like receptor, subfamily A, member 4 Klra4 Chinese hamster ovary killing allele
Killer cell lectin-like receptor, subfamily B, member 1C Klrb1c NA
Granulocytes SRY-box containing gene 13 Sox13 NA
Cytochrome b-245, beta polypeptide Cybb Dysregulated inflammatory response
Neural cell adhesion molecule 1 Ncam1 Reduced brain size
Prostaglandin-endoperoxide synthase 1 Ptgs1 Decreased inflammatory response
Apoptosis-associated tyrosine kinase Aatk NA
Monocytes E26 avian leukemia oncogene 2, 30 domain Ets2 Absent vitelline blood vessels
Prostaglandin-endoperoxide synthase 2 Ptgs2 Myeloid hyperplasia in spleen
Colony stimulating factor 1 receptor Csf1r Mononuclear phagocyte deficiency
Macrophage scavenger receptor 1 Msr1 Decreased ability to fight infection
Interleukin 1 receptor accessory protein Il1rap Required for IL-1 signaling
Erythrocytes GATA binding protein 1 Gata1 Abnormal erythropoiesis and anemia
Pyruvate kinase liver and red blood cell Pklr Hemolytic anemia
Intercellular adhesion molecule 4 Icam4 NA
Acetylcholinesterase Ache Postnatal lethality
Glial fibrillary acidic protein Gfap Increased susceptibility to injury
Lineage Zinc finger protein, subfamily 1A, 3 (Aiolos) Zfpn1a3 Abnormal lymphocyte proliferation,
candidate for lupus
CD48 antigen Cd48 Abnormal T cell development and
proliferation
POU domain, class 2, associating factor 1 Pou2af1 Abnormal B cell development584 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc.
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Fingerprint Gene Name
Gene
Symbol Knockout Phenotypes from MGI
Protein phosphatase 1, regulatory subunit 10 Ppp1r10 NA
Leukocyte Ig-like receptor, subfamily B, member 4 Lilrb4 Abnormal hematopoiesis and immune
response
Myeloid Toll-like receptor 4 Tlr4 Increased susceptibility to bacterial
infection
Pre-B cell leukemia transcription factor 1 Pbx1 Embryonic lethality from anemia and
fewer myeloid progenitors
Bone marrow stromal cell antigen 1 Bst1 NA
Leukocyte receptor cluster (LRC) member 4 Leng4 NA
Triggering receptor expressed on myeloid cells 1 Trem1 NA
Lymphoid CD2 antigen Cd2 No phenotype reported
Lymphocyte antigen 9 Ly9 NA
Dual specificity phosphatase 19 Dusp19 Not examined
Fibroblast growth factor 13 Fgf13 NA
Plasmacytoma variant translocation 1 Pvt1 NA
Representational fingerprint genes are listed by gene name and Entrez Gene symbol for each fingerprint. Knockout phenotypes are
included where applicable according to Mouse Genome Informatics version 3.44.
Key: ‘‘Lineage’’ fingerprint, genes expressed in all cell types except the HSC; ‘‘Myeloid’’ fingerprint, genes expressed in both
monocytes and granulocytes, but not other cell types; ‘‘Lymphoid’’ fingerprint, genes expressed in NK, T (all subsets), and B cells,
but not the other cell types; ‘‘NA,’’ those genes where no knockout has been reported; ‘‘No phenotype reported,’’ genes where
hematopoiesis was examined and no phenotype was found.chromatin would translate into measurable expression by
cohorts of chromosomally adjacent genes. We generated
a map, for each cell type, of all transcribed genes (using
4.5 as the expression threshold), and identified genes
within windows of at least 20 adjacent coexpressed probe
sets (representing 14 genes on average). We then sub-
tracted each cell type’s chromosomal expression map
from the chromosomal expression maps of each other
population to observe differences in chromosomal tran-
scribed regions, as illustrated in Figure 6A. (The com-
plete set of comparative analyses, including 2000 maps,
is downloadable at http://franklin.imgen.bcm.tmc.edu/
loligag/). To assess this novel method we examined two
loci known to be regulated via chromatin remodeling: the
interleukin-4/interleukin-13 locus on chromosome 11 (Ro-
gan et al., 2004) and the globin locus on chromosome 7 (Li
et al., 2002). Both loci were found to have a higher density
of transcription within the anticipated cell type (activated T
cells and nucleated erythrocytes, respectively; Figure S5).
When HSCs were compared to all other cell types across
the X chromosome, the HSCs exhibited many more re-
gions of open chromatin, evidenced by peaks on the plots.
The reverse is true for the erythrocytes (Figure 6B), with
mostly valleys. By calculating the area under the curve,
the percentage of open chromatin for each cell type was
determined and displayed graphically for each chromo-
some (Figure 6C; the entire set, including tabular repre-
sentation, is available at http://franklin.imgen.bcm.tmc.
edu/loligag/). On all chromosomes except 17, the chroma-Celltin is highly accessible in HSCs, relative to the other cell
types. Remarkably, the X chromosome displays an ex-
treme degree of openness. The same analysis with mono-
cytes shows a variable degree of chromatin accessibility,
while erythrocytes were largely closed except for chromo-
some 14. The marked openness of chromosome 14 in
erythrocytes may indicate the presence of a number of
linked genes involved in erythrocyte generation.
Fingerprint Transcription Factors Can Bias
Differentiation to Their Lineage
To test whether the lineage fingerprints contain genes
involved in lineage specification, we attempted to bias
hematopoietic differentiation by overexpression of puta-
tive regulatory fingerprint transcription factors. We chose
three transcription factors: Sox13, Ets2, and Zfp105
from the granulocyte, monocyte, and NK cell fingerprints,
respectively. Ets2 is member of the ETS family of tran-
scription factors and is implicated in acute myeloid leu-
kemia (Aperlo et al., 1996); Zfp105 has so far only been
implicated in spermatogenesis (Przyborski et al., 1998).
MSCV-based retroviral vectors containing each of the
genes coupled to eGFP via an IRES were used to trans-
duce bone marrow progenitors, which were then trans-
planted into lethally irradiated recipients (Figure 7A). Pe-
ripheral blood of the recipients was analyzed 12 weeks
after transplantation for the proportion of transduced
GFP+ cells in different blood lineages, compared to
controls (transduced with GFP vector alone). Sox13Stem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 585
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Hematopoietic Fingerprints: An Expression DatabaseFigure 6. Chromosomal Expression Density Indicates a More Open Chromatin State for HSCs Compared to Other Cell Types
(A) Chromosomal expressionmapswere plotted as described in the text and then subtracted against each other. On the X chromosome, HSCs exhibit
many more regions where multiple adjacent genes are expressed, seen as the curve above the gray line (representing 0, or no difference between the
cell types).
(B) The converse is true for erythrocytes on the X chromosome.
(C) On a per chromosome basis, differences in expression density between cell types were determined, where a positive value (% more open)
represents a greater number of expressed genes and open chromatin for the indicated cell type compared to each other cell type. Results indicate
more open chromatin for HSCs and a closed chromatin state for n-Er. Chromosomes 17 and 8 are relatively more open in monocytes, whereas there
are more highly expressed regions on chromosome 14 in erythroid cells.overexpression had no discernible effect on lineage distri-
bution (data not shown). However, Ets2 overexpression
resulted in an increase in myeloid cells, and a decline in
T cells (Figure 7B). When the F4/80 marker was used to
specifically track monocytes, an 4-fold increase in
monocytes derived from Ets2-transduced cells was evi-
dent in the peripheral blood, relative to controls (two-sam-586 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elsevierple t test assuming equal variances, two-sided p% 0.007,
alpha = 0.05), indicating that overexpression of Ets2 can
bias differentiation toward the monocyte lineage. Even
more striking were the results of overexpression of
Zfp105. Both T and B cells were significantly reduced in
the Zfp105-overexpressing cells relative to controls (Fig-
ure 7C). NK cells, enumerated using the NK1.1 marker,Inc.
Cell Stem Cell
Hematopoietic Fingerprints: An Expression DatabaseFigure 7. Retroviral Transduction of
Fingerprint Genes Ets2 and Zfp105
Biases Cell Fate
(A) HSCs were transduced using an MSCV-
based vector that generates a bicistronic
mRNA containing eGFP linked to either Ets2
or Zfp105. The control vector contained eGFP
alone. Transduced cells were transplanted
into recipients, and eGFP-positive blood was
analyzed 12 weeks later and compared to the
eGFP-vector control.
(B) The proportion of total transduced blood
cells (transduction, Tx.), transduced myeloid,
and transduced lymphoid cells was deter-
mined (left; error bars represent standard error;
GFP, n = 6; Ets2, n = 9). Compared to vector
control, Ets2 enhanced myeloid differentiation
to the detriment of T cell contribution. F4/80-
positive transduced monocytes in the blood
were elevated (p% 0.007).
(C) Zfp105 transplants exhibited a depression
in B and T cells, and low transduction (left;
GFP, n = 5; Zfp105, n = 4). NK1.1-positive
GFP + NK cells in peripheral blood were ele-
vated 5-fold (p% 105). (P values are based
on a two-sample t test assuming equal vari-
ances, alpha = 0.05.) Asterisk (*) indicates a
P value% 0.05.showed a greater than 5-fold increase (two-sample t test
assuming equal variances, two-sided p % 106, alpha =
0.05). Interestingly, the total percentage of Zfp105-trans-
duced cells was quite low in these mice (2% at 12
weeks, compared to 18% in GFP alone), suggesting
that overexpression of a powerful differentiation factor is
incompatible with maintenance of stem cell function.
These data do not exclude the possibility that overexpres-
sion of Ets2 and Zfp105 exerts their effects on cell-type
representation in part by increasing cell survival or prolifer-
ation; the mechanism through which these genes act will
require more in-depth analysis.
DISCUSSION
We have taken a systematic approach to identifying the
molecular components of the hematopoietic system, in-
cluding stem cells and their differentiated counterparts.
The unique cellular fingerprints enabled us to identify
genes exclusively expressed in specific cell types, or
shared by related populations. These fingerprints contain
some known genes, and ablation of many of the genes
results in a phenotype consistent with their expression
pattern (Table 1).Cell StThe fingerprints also contain many unstudied genes,
some of which may play a functional role, and others
which may regulate other genes in that fingerprint, thus
participating in cell type specification. The proportion of
genes currently identified as unnamed Riken clones or
other expressed sequence tags (ESTs) ranged from 14%
in HSCs to 35% in naive T cells, with an average of 25%
in the lineage-specific fingerprint genes. These data open
many new avenues for study in all of the populations we
have characterized, and we predict that modulation of
at least some of these unknown genes would impact
hematopoiesis.
Someof thesefingerprint genesmaybeusedasmarkers
to uniquely identify and purify particular populations.While
markers are available for many cell types, these have been
developed empirically over the years and in many cases
are not exclusively expressed on the population of interest,
complicating data analysis. For example, an unexploited
cell surface marker whose expression is common to the
differentiated cells is CD82. In contrast is theHSC-specific
Tie2, shown to be important in maintaining HSC quies-
cence (Arai et al., 2004). All of the fingerprints contain
additional cell surface molecules that could be used to
develop new cell-identification strategies.em Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 587
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potential new regulators of HSCs and of hematopoietic
differentiation. Each fingerprint contains transcription
factors that are candidates for playing a regulatory role
in that population. As shown above, overexpression of
two of these, Ets2 and Zfp105, unique to monocytes and
NK cells, respectively, resulted in significantly biased
differentiation toward their respective lineages. Again,
each fingerprint contains a number of other candidate reg-
ulators that could be similarly exploited. Regulators that
are truly unique to specific lineages could be a powerful
tool to modulate production of those cell types for thera-
peutic purposes. For example, inhibition of gene products
specific to activated T cells may be useful in autoimmune
disease; similarly, inhibition of products specific to B cells
could be applied to inhibit production of B cells in B cell
lymphoma, as has been shown to be clinically successful
in theapplicationof anti-CD20antibody (Presset al., 1987).
Analysis of the fingerprints using KEGG (Figure 5)
showed distinct pathways enriched in different cell types.
HSCswere notably enriched in theWnt signaling pathway,
which has previously been implicated in self-renewal
(Reya et al., 2003) but not explored in depth. We found
members of both canonical and noncanonical Wnt path-
way activation in stem cells, including unique expression
in HSCs of multiple Wnt receptor genes (Fzd3, 4, 6, 7),
as well as the tyrosine kinase Ryk, thought to be involved
in noncanonical Wnt signal transduction (Cadigan and Liu,
2006). Other members of the Wnt signal-transduction
pathway, such as disheveled 1 and b-catenin, were pres-
ent in all cell types examined.
Also emerging from these data is the observation that
a number of cell-type-specific genes are associated with
oncogenic transformation when aberrantly expressed in
other cell types. For example, Pbx1, a shared myeloid
fingerprint, is vital to myeloid development and differenti-
ation (Piccaluga et al., 2006) but is commonly found over-
expressed in B cell leukemia. Likewise, Evi1, an HSC
fingerprint gene, is frequently involved in human myeloid
leukemias (Barjesteh van Waalwijk van Doorn-Khosrovani
et al., 2003).
HSCs had the largest fingerprint, with over 10% of the
genes being proven or putative transcription factors.
This suggests that quiescent HSC are poised for action
and ready to differentiate. This is consistent with the idea
of stem cell priming (Hu et al., 1997; Jimenez et al., 1992),
where many genes in stem cells are accessible, and in
some cases already expressing low levels of differentia-
tion markers (Akashi et al., 2003). The observation that
ES cells show similarly ‘‘poised’’ patterns of regulation at
the chromatin level (Boyer et al., 2005) suggests that even
disparate kinds of stem cells may use similar strategies to
effect rapid differentiation. Our chromatin state analysis
also supports this idea, by showing that in HSCs, nearly
every chromosome is more open, as measured by coex-
pressed adjacent genes. The X chromosome exhibited
an extreme degree of openness, consistent with a previ-
ous observation that there are a large number of active
genes on the X chromosome in HSCs (Forsberg et al.,588 Cell Stem Cell 1, 578–591, November 2007 ª2007 Elsevier2005). Genetic linkage analysis has also implicated the X
chromosome in regulation of HSCs (Henckaerts et al.,
2002). The quantitative trait locus (QTL) scpro11 is found
within an open region of this chromosome, providing evi-
dence for the importance of an X chromosome with open
chromatin for stem cell function (Geiger et al., 2001).
Equally striking was the degree to which chromosome
17, which also contains aQTL determining HSC frequency
(Morrison et al., 2002), appearedmost closed in HSC. Pre-
vious work from our lab showed that several genes on
chromosome 17 become upregulated when HSCs are
stimulated to proliferate (Venezia et al., 2004), suggesting
a role in maintenance of quiescence.
Other investigators have used expression profiling to
identify HSC-enriched genes (Akashi et al., 2003; Ram-
alho-Santos et al., 2002). We found that the majority of
these were found in our data to be expressed in HSCs
(94%within Ramalho-Santos et al. and 78%within Aka-
shi et al.), suggesting high similarity between the analyzed
cell populations; however, few of these were found to be
specific to HSCs according to our fingerprint analysis.
Nevertheless, eleven of our HSC fingerprint genes were
foundwithin one or the other HSC-enriched lists (Ghr,Ryk,
Gab1, Yes1, Yap1, Tead2, Gsta4, Meis1, Gata-2, TCF-3,
and Nr4a2). The lack of overlap between our HSC finger-
print list and other HSC-enriched gene lists likely reflects
the different comparator populations used to generate the
lists. TheRamalho-Santos and Akashi studies respectively
used ES and neural stem cells or hematopoietic progeni-
tors as their comparators, whereas we used differentiated
hematopoietic cells. Further comparison of our expression
data to that obtained from other studies of differentiated
hematopoietic lineages may yield additional insights.
To our knowledge, this resource is the first broad mo-
lecular portrait of any developmental system including
a stem/progenitor cell and most major progeny. The data-
base is the first step toward a comprehensive transcrip-
tional profile of the entire hematopoietic system, and in
the future may be refined with the addition of other cell
types (e.g., megakaryocytes and progenitors), as well as
the use of platforms that enable analysis of the complete
coding and noncoding genomes. Even the current data
set can be more deeply mined as some of the poorly char-
acterized transcripts represented on the arrays are bet-
ter annotated or newer array analysis strategies become
available. Nevertheless, the data and analyses presented
offer a resource for further investigation into the regulation
of HSCs and their differentiation. The wealth of genes
identified as candidates for functional and regulatory roles
in hematopoietic cells will enable new lines of investigation
and therapeutic approaches to modulate the activity of
these cell types.
EXPERIMENTAL PROCEDURES
Mice and Cell Purification
All cell types were purified according to published protocols using
a combination of magnetic and flow cytometric cell sorting to achieve
at least 95% purity. Details are given in Table S1. C57Bl/6-CD45.1Inc.
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acidified water and mouse chow ad libitum were used. Cells were pu-
rified from 8- to 12-week-old female mice; each population was puri-
fied on two separate occasions from pools of tissue from at least
four mice (biological replicates). RNA from all samples were processed
together and were amplified from approximately the same number of
cells prior to hybridization to Affymetrix MOE430 2.0 microarrays,
which include 45,000 probe sets representing about two-thirds of
the coding genome. Nucleated erythrocytes from whole bone marrow
(WBM) were Ter-119+, CD3, CD4, CD8, Mac-1, Gr-1, and
B220. Granulocytes (from WBM) were Gr-1+, clone 7/4+ (Cedarlane
Labs), CD2, CD5, B220, F4/80 (eBiosciences), ICAM-1, and
Ter-119. LT-HSCs were isolated as shown previously (Camargo
et al., 2006). Briefly, WBM was stained with Hoescht 33342, and the
Sca-1+ cells were enriched by magnetic separation, followed by flow
cytometry for side population (SP) and Sca-1+, c-Kit+, and Lin
(Mac-1, Gr-1, Ter119, B220, CD4, CD8; eBiosciences). Naive T cells
were freshly isolated from spleen as CD4+, CD25, CD69 or CD8+,
CD25, and CD69. Activated T cells were isolated by enriched naive
T cells with Concanavalin A (1 mg/ml, Sigma) for 8–11 hr followed by
sorting for CD25+ and CD69+. B cells were CD19+ and 33D1 spleno-
cytes. Monocytes were isolated from PB based on forward and side
scatter properties as well as being Mac-1+. NK cells from spleen were
Nk1.1+ CD3 cells.
RNA Purification and Hybridization to Microarrays
RNA was isolated from 1 3 105 cells (except for HSCs, which were
from 2.5–5 3 104 cells), using the RNAqueous kit (Ambion, Austin,
TX, USA), treatedwith DNase I, and precipitatedwith phenol:chlorofor-
m:isoamyl alcohol. The RNA was linearly amplified as previously re-
ported (Venezia et al., 2004). Briefly, two rounds of T7-based in vitro
transcription using the MessageAmp kit (Ambion) were undertaken,
and the RNA was labeled with biotin-conjugated UTP and CTP (Enzo
Biotech). Amplified biotinylated RNA (20 ug) was diluted in fragmenta-
tion buffer, incubated at 94C for 25 min, and stored at –80C. A sam-
ple was run on a 4% agarose gel to confirm an RNA fragment length of
50 bp. The labeled RNA was hybridized to MOE430.2 chips accord-
ing to standard protocols. For signal amplification, the chips were
washed and counterstained with PE-conjugated streptavidin and a bi-
otinylated anti-streptavidin antibody. The raw image and intensity files
were generated using GCOS 1.0 software (Affymetrix). All microarrays
used in this study had to pass several quality control tests, including
a scale factor < 5, a 50 to 30 probe ratio < 20, and replicate correlation
coefficient > 0.96.
Microarray Analysis
Normalization and model-based expression measurements were per-
formed with GC-RMA. GC-RMA, as well as additional analytical and
annotation packages, is available as part of the open-source Biocon-
ductor project (www.bioconductor.org) within the statistical program-
ming language R (http://cran.r-project.org/) (Team, R.D.C., 2006).
Cluster analysis and PCA were performed with the R base package.
Lineage fingerprints were established by setting on/off expression
thresholds (off < 4, on > 5) and using Boolean logic to find uniquely
expressed genes in each cell type and each grouping. When selecting
a T cell fingerprint, activated T cells were removed from the data set
and naive T cells (both CD4+ and CD8+) were averaged together.
The FDR q value for each list ranged between 0.00185 and 0.08933.
RT-PCR Analysis
RNA was isolated using the RNAqueous kit (Ambion) from FACS-
sorted cells isolated independently from the samples used for array
analysis. For qRT-PCR, RNA was reverse transcribed with random
hexamer primers using Super Script II (Invitrogen). cDNA input was
standardized and qRT-PCRs were performed with Taqman master
mix, 18 s-rRNA probe (VIC-MGB), and a gene-specific probe (FAM-
MGB, Applied Biosystems) for 55 cycles using an AbiPrism 7900HT
(Applied Biosystems). For standard RT-PCR used to confirm T cellCellgenes, RNA was prepared as above with the addition of DNase I trea-
ment before RT followed by phenol:chloroform extraction. cDNA
input was standardized, and PCR was performed for 40 cycles.
The reader should note that some genes (e.g., Evi1) are represented
by multiple probe sets, which in some cases give differing results, typ-
ically appearing with a differential expression profile for one set, and
appearing as ‘‘off’’ in all cell types with other probe sets. This is due
to variations in the efficacy of Affymetrix probe sets, and the 50 bias
of some probe sets. False positives are much less likely than false neg-
atives, so we assume the positive probe set is correct, as borne out by
the analysis shown in Figure S1 with Evi1. The reader is urged to verify
expression profiles of particular interest with qRT-PCR and to be
aware of the limitations of Affymetrix probe sets (Allison et al., 2006).
Knockout Analysis
All knockout data were obtained via the 3.44 MGI database (http://
www.informatics.jax.org/). The phenotypes are classified into a hierar-
chical tree with the terminal categories being very precise descriptions
and the initial categories being very broad descriptions. To obtain all
knockouts, the ‘‘hematopoietic system phenotype’’ and ‘‘immune sys-
temphenotype’’ were grouped into a single list (‘‘hematopoietic knock-
out data’’). All genes on the array that have a reported knockout were
identified. The frequency of fingerprint genes that have ahematopoietic
phenotype was compared to the frequency of hematopoietic knock-
outs found by chance within all knock-out data. A Z statistic was
used to determine the significance of enrichment fingerprint genes
found within the knockouts with a reported hematopoietic phenotype
and reported in Table S4. A Z statistic above 3 SD was considered
significant for this enrichment.
KEGG Analysis
KEGG is a suite of gene databases systematically organized into met-
abolic and signaling pathways (http://www.genome.ad.jp/kegg/)
(Ogata et al., 1999). The mean expression value for each KEGG path-
way was obtained by taking the mean of the expression values of each
gene on the microarray for a given KEGG pathway. The mean expres-
sion value of all KEGG pathways for each hematopoietic cell type was
obtained using all the genes on the array (not limited to the finger-
prints). An ANOVA to identify pathways with a significant variation be-
tween the cell types (ANOVA p value % .05) was performed, and 65
significant pathways were identified. The pathways were then ranked
by maximal abundance for each cell type and a heat map was gener-
ated using the centered data, enabling identification of differences in
KEGG pathway activity between each of the cell types. KEGG path-
ways equally active in all cell types will not appear significant.
Chromosomal Analysis
Affymetrix probes were assigned a value of 1 if their expression value
was equal to or greater than 4.5 and 0 if they were below 4.5. Each
probe was then plotted to its chromosomal position, and a chromo-
somal expression map was created for each chromosome for each
cell type by an R function we developed. Briefly, this function uses
a sliding and overlapping window, which covers 20 probe sets (repre-
senting 14 genes on average) at one time and overlaps with the previ-
ous nineteen, that takes the sum of 1s within the window for the y
axis and the mean chromosomal position for the x axis and uses these
values to plot the expression map. For comparison between cell types,
the expressionmap of one cell typewas directly subtracted from all the
other cell types in turn. To quantitate openness of chromatin we calcu-
lated the area under the curves and divided that by the possible area
under the curve (if all y values were 20) to calculate a percentage of
more open chromatin as shownby the chromosomal expressionmaps.
Retroviral HSC Transduction
Clones for Ets2, Zfp105, and Sox13 were TA cloned into a pENTR/D-
TOPO vector, and the Gateway system was used to recombine Ets2,
Zfp105, and Sox13 into a murine stem cell virus (MSCV) vector con-
taining attR recombination sites. Vectors were packaged using 293TStem Cell 1, 578–591, November 2007 ª2007 Elsevier Inc. 589
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mice were treated with 5-fluorouracil (150 mg/kg, American Pharma-
ceutical Partners) 6 days before harvesting WBM. WBM was enriched
for Sca-1+ cells using magnetic enrichment (AutoMACS, Miltenyi) and
adjusted to a concentration of 5 3 105 cells/ml in transduction me-
dium, containing Stempro 34 (GIBCO), nutrient supplement, penicil-
lin/streptomycin, L-glutamine (2 mM), mSCF (10 ng/ml, R&D Systems),
mTPO (100 ng/ml, R&D Systems), and polybrene (4 ug/ml, Sigma).
Thawed virus was applied at an moi of 1, and the suspension was
spin infected at 250 3 g at room temperature for 2 hr (Kotani et al.,
1994). After transduction, the cells were incubated at 37C for 3 hr
and transplanted into lethally irradiated CD45.1 mice. Engraftment,
transduction, and lineage analysis were performed on peripheral blood
12 weeks after transplantation by FACS (FACSaria, BD). The lineage
analysis method is shown in Figure S3.
Supplemental Data
Supplemental Data include five figures and five tables and can be
found with this article online at http://www.cellstemcell.com/cgi/
content/full/1/5/578/DC1/.
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